Washington, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) on Thursday authorized American pharmaceutical company Merck’s oral antiviral for the treatment of mild-to-moderate COVID-19, the second pill approved for treating COVID-19 following the one from Pfizer. Merck’s pill, called molnupiravir, is authorized to use in adults with positive …
Read More »U.S. FDA authorizes first oral antiviral for COVID-19 treatment
Washington, U.S. | Xinhua | The U.S. Food and Drug Administration on Wednesday authorized Pfizer’s oral antiviral tablets for the treatment of mild-to-moderate COVID-19, the first pill approved for COVID-19 treatment in the country. The pill, called Paxlovid, is authorized for use in adults and pediatric patients 12 years of age …
Read More »